OTTAWA, October 14, 2021 – Research Canada: An Alliance for Health Discovery is pleased to welcome twelve new Members into its Alliance dedicated to advancing health research and innovation in Canada: Arthritis Society, BD Canada, Eastern Regional Health Authority (Eastern Health), École de technologie supérieure (ÉTS), Johnson & Johnson, Memorial University’s Faculty of Medicine, Micellae Delivery Systems, Ovarian Cancer Canada, Ryerson University, Simon Fraser University, Université de Montréal’s Faculty of Medicine and VoxCell BioInnovation.
“Our influence as an organization is rooted in the sector and geographic diversity of our membership,” says Dr. Rosie Goldstein, Chair of Research Canada and Professor of Medicine at McGill University. “We are delighted to be furthering Research Canada’s advocacy efforts through the unique and diverse perspectives of these extraordinary organizations from across the country,” says Deborah Gordon-El-Bihbety, President and CEO of Research Canada.
Research Canada engages all sectors – including government – to build support for health research and innovation. The addition of these new Members into the Alliance strengthens the organization’s ability to represent the interests of the health innovation ecosystem as a whole.
“We are thrilled to be welcoming these new Members into the fold, particularly during a year that has been challenging for so many institutions,” says Lori Spadorcia, Chair of Research Canada’s Membership Development and Programs Committee and Senior Vice-President of Public Affairs and Partnerships, Chief Strategy Officer at the Centre for Addiction and Mental Health. “The health of Canadians is so positively impacted by the enormous amount of research knowledge and practice that these organizations represent. Their work will undoubtedly inspire our ongoing advocacy efforts,” adds Ms. Spadorcia.
About Research Canada
Research Canada is a national alliance dedicated to increasing investments in health research through collaborative advocacy and engaging government, academia, industry and non-profit sectors to build support for long-term health research funding. For more information, visit rc-rc.ca.
For inquiries:
Danielle Flieler
Manager of Membership and Development
613-234-5129
dflieler@rc-rc.ca
ADDITIONAL INFORMATION
Research Canada advocates for the prioritization of health research and health innovation in the government to improve the health of Canadians. These new Members provide a breadth of knowledge and expertise across many stages of the research continuum.
The Arthritis Society is Canada’s national charity dedicated to creating a world where people are free from the devastating effects of arthritis. The Arthritis Society represents the six million Canadians living with arthritis today, and the millions more who are impacted or at risk.
BD Canada is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research, enhance diagnostic capabilities, improve and support patient care, and equip surgical and interventional procedures.
The Eastern Regional Health Authority (Eastern Health) is Newfoundland and Labrador’s largest integrated health authority, providing a number of health and community services, including public health, long-term care and acute (hospital) care. Eastern Health offers a full continuum of health and community services and unique provincial programs and services to ensure they are providing high quality, safe, accessible and sustainable health care.
The École de technologie supérieure (ÉTS) is a constituent establishment of the Université du Québec. ÉTS, which specializes in engineering and technological transfer education as well as applied research, trains engineers and researchers who are recognized for their practical and innovative approach. Over the past four years, total research funding to ÉTS has grown by a phenomenal 55%.
Johnson & Johnson Inc. is part of the world’s largest and most broadly-based healthcare company (comprised of Consumer Health, Pharmaceuticals and Medical Devices). Johnson & Johnson is committed to using its reach and size for good every day, and for more than 100 years in Canada, it has aimed to keep people well at every age and every stage of life.
The Faculty of Medicine at Memorial University of Newfoundland offers a four-year undergraduate medical program that provides a comprehensive and integrated medical education. The size of the faculty and the student body facilitate a personalized learning environment. An integrated approach to the field of medicine is encouraged by a non-departmental administration system based on three divisions: Community Health and Humanities, BioMedical Sciences and the Clinical Sciences.
Micellae Delivery Systems is an innovative technology-based company founded on 15 years of research and engineering at University of Toronto. Micellae aims to provide the most advanced Drug Delivery System to high-quality pharmaceutical, medical and recreational cannabis producers.
Ovarian Cancer Canada champions the health and wellbeing of women with ovarian cancer and others at risk of this disease while advancing research to save lives. As the only registered Canadian charity solely dedicated to overcoming ovarian cancer, the organization provides leadership in research, advocacy, and support, so that women live fuller, better, longer lives.
Ryerson University is at the intersection of mind and action. What their students learn in the classroom is enhanced by real-world knowledge and experience. Ryerson champions diversity, entrepreneurship and innovation. Research funding and publications have doubled in the past five years at Ryerson. Their interdisciplinary approach to research represents the collaboration of over 125 centres, institutes and labs and over 190 local, national and global funding partners.
Established in 1965, Simon Fraser University (SFU) has become Canada’s leading comprehensive university, with three vibrant urban campuses and deeply rooted partnerships at home and around the world. SFU is one of Canada’s top research-intensive universities, consistently placing among Canada’s top 15 research universities in global and national university rankings, and is among the fastest growing research-intensive universities in Canada.
The Université de Montréal’s Faculty of Medicine is a pioneering institution dedicated to education and research based on ACTIVE participation in the advancement of knowledge and the development of skills to improve health care. As an internationally renowned institution and one of the university’s founding faculties, the Faculty of Medicine has the threefold mission of education, research and the improvement of health in the areas of clinical sciences, basic sciences and health sciences.
VoxCell BioInnovation is providing an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. Testing on truly biomimetic tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life-saving therapies to market and in the hands of people who need them sooner.